Categories: Health

KFSHRC Advances Robotic Surgery with a Successful Ivor Lewis Esophagectomy


RIYADH, Saudi Arabia, July 30, 2025 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh successfully performed a robotic Ivor Lewis esophagectomy, the first of its kind in the Middle East, on a 46-year-old male diagnosed with gastroesophageal junction adenocarcinoma, a type of cancer located near the area where the esophagus meets the stomach. The patient regained mobility within two days of surgery, began oral intake by day five, and was discharged within ten days. This outcome demonstrates the effectiveness of the robotic approach in reducing pain, minimizing complications, and accelerating recovery compared to conventional surgery.

The procedure was led by Dr. Khalid Aldaghri, Consultant in bariatric, upper gastrointestinal, and robotic surgery at KFSHRC. Utilizing the Ivor Lewis technique, a complex and technically demanding procedure involving two phases. The abdominal phase involved stomach mobilization and creation of a gastric conduit. This was followed by the thoracic phase, in which the diseased esophagus was resected and the conduit is robotically connected within the chest.

Precision in the robotic system enabled surgeons to reach deep anatomical areas without large incisions, enhancing safety, reducing risks, and improving outcomes in one of the most complex cancer surgeries.

Close collaboration among surgical, anesthesia, nursing, and technical teams was key to the procedure’s success. All teams worked synchronously across every stage, from pre-op planning to post-op recovery. This approach reflects KFSHRC’s multidisciplinary model of care, designed to improve patient outcomes and boost clinical efficiency.

With its advanced features, the robotic surgery significantly enhanced the safety and accuracy of the esophagectomy by offering three-dimensional high-definition visualization, stable instrument control, and superior access within confined anatomical spaces. These capabilities enabled more precise dissection, better preservation of surrounding structures such as nerves and vessels and reduced intraoperative risks. The technology also made it physically easier for the surgeon to operate over an extended period.

As a medical milestone, the success of this procedure opens the door for broader applications of robotic surgery at KFSHRC. It enables more patients to benefit from advanced surgical techniques and reinforces the institution’s commitment to clinical innovation, safety, and effective alternatives to traditional surgical approaches.

It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world’s top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/45f95dc0-9a6c-4e12-a353-2c329acd9c9b

GlobeNews Wire

Recent Posts

Shiny Smile Veneers 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

New York City, NY, March 14, 2026 (GLOBE NEWSWIRE) -- For anyone who has been…

11 hours ago

Lean Drops Announces USA & Canada Debut: Introducing LeanDrops Weight Management Liquid Formula

New York City, NY, March 14, 2026 (GLOBE NEWSWIRE) -- Lean Drops, an innovative liquid…

11 hours ago

Sugar Harmony (2026 CONSUMER REPORT): Tainted Supplement Warning Issued as “Glucose Reset Ritual” Goes Viral

New York City, NY, March 14, 2026 (GLOBE NEWSWIRE) -- Sugar Harmony: SugarHarmony Research has…

11 hours ago

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

March 14, 2026 10:15 ET  | Source: Senseonics Holdings, Inc. New data shows positive real-world…

14 hours ago

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,”…

14 hours ago

AgelessRx 2026: Longevity Telehealth Platform Overview Treatments, Pricing, Compounded Medications, and What Prospective Patients Should Know

Ann Arbor, MI, March 13, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational…

14 hours ago